OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Multispecies-targeting siRNAs for the modulation of JAK1 in the skin
Qi Tang, Katherine Y. Gross, Hassan H. Fakih, et al.
Molecular Therapy — Nucleic Acids (2024) Vol. 35, Iss. 1, pp. 102117-102117
Open Access | Times Cited: 11

Showing 11 citing articles:

RNAi-based drug design: considerations and future directions
Qi Tang, Anastasia Khvorova
Nature Reviews Drug Discovery (2024) Vol. 23, Iss. 5, pp. 341-364
Open Access | Times Cited: 63

Principle, application and challenges of development siRNA-based therapeutics against bacterial and viral infections: a comprehensive review
Hamid Motamedi, Marzie Mahdizade Ari, Amirhoushang Alvandi, et al.
Frontiers in Microbiology (2024) Vol. 15
Open Access | Times Cited: 8

Sequence-Defined DNA Polymers: New Tools for DNA Nanotechnology and Nucleic Acid Therapy
Muhammad Ghufran Rafique, Quentin Laurent, Michael D. Dore, et al.
Accounts of Chemical Research (2025) Vol. 58, Iss. 2, pp. 177-188
Closed Access

Recent clinical and mechanistic insights into vitiligo offer new treatment options for cell-specific autoimmunity
Khaled Ezzedine, Rim Tannous, T. Pearson, et al.
Journal of Clinical Investigation (2025) Vol. 135, Iss. 2
Closed Access

JAKing up immunity
Massimo Gadina, John J. O’Shea
Science (2024) Vol. 384, Iss. 6702, pp. 1303-1304
Closed Access | Times Cited: 3

Cholesterol Conjugates of Small Interfering RNA: Linkers and Patterns of Modification
Ivan V. Chernikov, Ul’yana A. Ponomareva, Mariya I. Meschaninova, et al.
Molecules (2024) Vol. 29, Iss. 4, pp. 786-786
Open Access | Times Cited: 2

Therapeutic targeting of siRNA/anti-cancer drug delivery system for non-melanoma skin cancer. Part I: Development and gene silencing of JAK1siRNA/5-FU loaded liposome nanocomplexes
Minela Aslan, Şükrü Öztürk, Reza Shahbazi, et al.
European Journal of Pharmaceutics and Biopharmaceutics (2024) Vol. 203, pp. 114432-114432
Closed Access | Times Cited: 2

Cross-species RNAi therapy via AAV delivery alleviates neuropathic pain by targeting GCH1
Heesue Chang, Kyoung Jin Lee, Minkyung Park, et al.
Neurotherapeutics (2024), pp. e00511-e00511
Open Access | Times Cited: 1

Development, Opportunities and Challenges of siRNA Nucleic Acid Drugs
Bowen Xiao, Shaopeng Wang, Yu Pan, et al.
Molecular Therapy — Nucleic Acids (2024) Vol. 36, Iss. 1, pp. 102437-102437
Open Access | Times Cited: 1

Near Sequence Homology Does Not Guarantee siRNA Cross-Species Efficacy
Iris Flores, Kathryn Monopoli, Samuel Jackson, et al.
Nucleic Acid Therapeutics (2024) Vol. 34, Iss. 5, pp. 234-244
Closed Access

mTOR Downregulation Promotes Anti-Inflammatory Responses via the CCL3-CCR5 Axis in Hypoxic Retinopathy
Tae Kwon Moon, Insug Kang, Kyoung Jin Lee, et al.
Molecular Therapy — Methods & Clinical Development (2024) Vol. 33, Iss. 1, pp. 101404-101404
Open Access

Page 1

Scroll to top